nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—CYP2D6—Hydroxyurea—head and neck cancer	0.119	0.355	CbGbCtD
Captopril—ALB—Fluorouracil—head and neck cancer	0.0921	0.275	CbGbCtD
Captopril—ABCB1—Vinblastine—head and neck cancer	0.0447	0.133	CbGbCtD
Captopril—CYP2D6—Vinblastine—head and neck cancer	0.0421	0.126	CbGbCtD
Captopril—REN—submandibular gland—head and neck cancer	0.0395	0.147	CbGeAlD
Captopril—ABCB1—Docetaxel—head and neck cancer	0.0368	0.11	CbGbCtD
Captopril—REN—forelimb zeugopod—head and neck cancer	0.0298	0.111	CbGeAlD
Captopril—Pemphigoid—Fluorouracil—head and neck cancer	0.0149	0.0866	CcSEcCtD
Captopril—ACE—forelimb zeugopod—head and neck cancer	0.0127	0.0472	CbGeAlD
Captopril—MMP2—cartilage tissue—head and neck cancer	0.0122	0.0454	CbGeAlD
Captopril—MMP9—cartilage tissue—head and neck cancer	0.0106	0.0394	CbGeAlD
Captopril—LTA4H—exocrine gland—head and neck cancer	0.00932	0.0347	CbGeAlD
Captopril—LTA4H—hair follicle—head and neck cancer	0.00888	0.0331	CbGeAlD
Captopril—REN—exocrine gland—head and neck cancer	0.00719	0.0268	CbGeAlD
Captopril—LTA4H—mouth—head and neck cancer	0.00697	0.026	CbGeAlD
Captopril—Gastric irritation—Hydroxyurea—head and neck cancer	0.00669	0.0389	CcSEcCtD
Captopril—MMP2—exocrine gland—head and neck cancer	0.00661	0.0246	CbGeAlD
Captopril—REN—mouth—head and neck cancer	0.00538	0.02	CbGeAlD
Captopril—MMP2—mouth—head and neck cancer	0.00495	0.0184	CbGeAlD
Captopril—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.00493	0.0287	CcSEcCtD
Captopril—LTA4H—parotid gland—head and neck cancer	0.00485	0.0181	CbGeAlD
Captopril—LTA4H—saliva-secreting gland—head and neck cancer	0.00465	0.0173	CbGeAlD
Captopril—REN—neck—head and neck cancer	0.0046	0.0171	CbGeAlD
Captopril—MMP9—mouth—head and neck cancer	0.0043	0.016	CbGeAlD
Captopril—LTA4H—connective tissue—head and neck cancer	0.00427	0.0159	CbGeAlD
Captopril—Peptic ulcer—Vinblastine—head and neck cancer	0.00425	0.0247	CcSEcCtD
Captopril—MMP2—neck—head and neck cancer	0.00423	0.0157	CbGeAlD
Captopril—MMP9—neck—head and neck cancer	0.00368	0.0137	CbGeAlD
Captopril—Blister—Hydroxyurea—head and neck cancer	0.0036	0.0209	CcSEcCtD
Captopril—REN—saliva-secreting gland—head and neck cancer	0.00359	0.0134	CbGeAlD
Captopril—LTA4H—trachea—head and neck cancer	0.00359	0.0133	CbGeAlD
Captopril—MMP2—parotid gland—head and neck cancer	0.00344	0.0128	CbGeAlD
Captopril—MMP2—saliva-secreting gland—head and neck cancer	0.0033	0.0123	CbGeAlD
Captopril—REN—connective tissue—head and neck cancer	0.0033	0.0123	CbGeAlD
Captopril—F2—neck—head and neck cancer	0.00321	0.0119	CbGeAlD
Captopril—REN—epithelium—head and neck cancer	0.00313	0.0117	CbGeAlD
Captopril—LTA4H—lymphoid tissue—head and neck cancer	0.00312	0.0116	CbGeAlD
Captopril—MMP2—connective tissue—head and neck cancer	0.00303	0.0113	CbGeAlD
Captopril—MMP2—epithelium—head and neck cancer	0.00288	0.0107	CbGeAlD
Captopril—LTA4H—thyroid gland—head and neck cancer	0.00284	0.0106	CbGeAlD
Captopril—Ulcer—Hydroxyurea—head and neck cancer	0.00274	0.0159	CcSEcCtD
Captopril—MMP9—connective tissue—head and neck cancer	0.00264	0.00981	CbGeAlD
Captopril—Blister—Fluorouracil—head and neck cancer	0.00259	0.0151	CcSEcCtD
Captopril—MMP2—trachea—head and neck cancer	0.00254	0.00947	CbGeAlD
Captopril—LTA4H—head—head and neck cancer	0.00252	0.00937	CbGeAlD
Captopril—MMP9—epithelium—head and neck cancer	0.0025	0.00932	CbGeAlD
Captopril—Necrosis—Fluorouracil—head and neck cancer	0.00238	0.0138	CcSEcCtD
Captopril—F2—connective tissue—head and neck cancer	0.0023	0.00856	CbGeAlD
Captopril—ACE—mouth—head and neck cancer	0.00229	0.00854	CbGeAlD
Captopril—MMP2—lymphoid tissue—head and neck cancer	0.00222	0.00825	CbGeAlD
Captopril—F2—epithelium—head and neck cancer	0.00218	0.00813	CbGeAlD
Captopril—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00211	0.0123	CcSEcCtD
Captopril—Renal failure acute—Hydroxyurea—head and neck cancer	0.00204	0.0119	CcSEcCtD
Captopril—MMP2—thyroid gland—head and neck cancer	0.00201	0.00749	CbGeAlD
Captopril—Ulcer—Fluorouracil—head and neck cancer	0.00197	0.0115	CcSEcCtD
Captopril—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00197	0.0115	CcSEcCtD
Captopril—ACE—neck—head and neck cancer	0.00196	0.0073	CbGeAlD
Captopril—REN—head—head and neck cancer	0.00194	0.00723	CbGeAlD
Captopril—MMP9—lymphoid tissue—head and neck cancer	0.00193	0.00717	CbGeAlD
Captopril—SLC15A1—epithelium—head and neck cancer	0.00186	0.00693	CbGeAlD
Captopril—MMP2—head—head and neck cancer	0.00179	0.00665	CbGeAlD
Captopril—LTA4H—lymph node—head and neck cancer	0.00176	0.00656	CbGeAlD
Captopril—Angina pectoris—Vinblastine—head and neck cancer	0.00174	0.0101	CcSEcCtD
Captopril—Necrosis—Docetaxel—head and neck cancer	0.00172	0.00998	CcSEcCtD
Captopril—Pancytopenia—Vinblastine—head and neck cancer	0.00169	0.00985	CcSEcCtD
Captopril—F2—lymphoid tissue—head and neck cancer	0.00168	0.00626	CbGeAlD
Captopril—Ageusia—Docetaxel—head and neck cancer	0.00166	0.00967	CcSEcCtD
Captopril—Pancreatitis—Hydroxyurea—head and neck cancer	0.00159	0.00928	CcSEcCtD
Captopril—MMP9—head—head and neck cancer	0.00155	0.00578	CbGeAlD
Captopril—Pancytopenia—Hydroxyurea—head and neck cancer	0.00154	0.00899	CcSEcCtD
Captopril—Photosensitivity—Fluorouracil—head and neck cancer	0.00154	0.00897	CcSEcCtD
Captopril—Neutropenia—Hydroxyurea—head and neck cancer	0.00152	0.00885	CcSEcCtD
Captopril—Agranulocytosis—Vinblastine—head and neck cancer	0.00148	0.00863	CcSEcCtD
Captopril—Oliguria—Docetaxel—head and neck cancer	0.00146	0.0085	CcSEcCtD
Captopril—Drug interaction—Docetaxel—head and neck cancer	0.00145	0.00845	CcSEcCtD
Captopril—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00142	0.00825	CcSEcCtD
Captopril—Pharyngitis—Vinblastine—head and neck cancer	0.00142	0.00824	CcSEcCtD
Captopril—Stomatitis—Hydroxyurea—head and neck cancer	0.00141	0.00822	CcSEcCtD
Captopril—ACE—connective tissue—head and neck cancer	0.0014	0.00523	CbGeAlD
Captopril—F2—head—head and neck cancer	0.00135	0.00504	CbGeAlD
Captopril—Blood pressure increased—Docetaxel—head and neck cancer	0.00135	0.00784	CcSEcCtD
Captopril—Hepatocellular injury—Docetaxel—head and neck cancer	0.00135	0.00784	CcSEcCtD
Captopril—ACE—epithelium—head and neck cancer	0.00133	0.00497	CbGeAlD
Captopril—Hallucination—Hydroxyurea—head and neck cancer	0.0013	0.00754	CcSEcCtD
Captopril—Cardiac arrest—Fluorouracil—head and neck cancer	0.00129	0.00749	CcSEcCtD
Captopril—Ataxia—Fluorouracil—head and neck cancer	0.00127	0.00741	CcSEcCtD
Captopril—Alopecia—Vinblastine—head and neck cancer	0.00126	0.00734	CcSEcCtD
Captopril—MMP2—lymph node—head and neck cancer	0.00125	0.00465	CbGeAlD
Captopril—Muscular weakness—Fluorouracil—head and neck cancer	0.00119	0.00695	CcSEcCtD
Captopril—Eosinophilia—Fluorouracil—head and neck cancer	0.00116	0.00674	CcSEcCtD
Captopril—Ill-defined disorder—Vinblastine—head and neck cancer	0.00115	0.00671	CcSEcCtD
Captopril—Alopecia—Hydroxyurea—head and neck cancer	0.00115	0.00669	CcSEcCtD
Captopril—Anaemia—Vinblastine—head and neck cancer	0.00115	0.00668	CcSEcCtD
Captopril—Angina pectoris—Fluorouracil—head and neck cancer	0.00114	0.00663	CcSEcCtD
Captopril—Malaise—Vinblastine—head and neck cancer	0.00112	0.00652	CcSEcCtD
Captopril—Pancytopenia—Fluorouracil—head and neck cancer	0.00111	0.00647	CcSEcCtD
Captopril—MMP9—lymph node—head and neck cancer	0.00109	0.00405	CbGeAlD
Captopril—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00107	0.00622	CcSEcCtD
Captopril—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00105	0.00612	CcSEcCtD
Captopril—Anaemia—Hydroxyurea—head and neck cancer	0.00105	0.00609	CcSEcCtD
Captopril—Discomfort—Vinblastine—head and neck cancer	0.00105	0.00608	CcSEcCtD
Captopril—ACE—lymphoid tissue—head and neck cancer	0.00103	0.00382	CbGeAlD
Captopril—Dermatitis bullous—Docetaxel—head and neck cancer	0.00102	0.00595	CcSEcCtD
Captopril—Malaise—Hydroxyurea—head and neck cancer	0.00102	0.00595	CcSEcCtD
Captopril—Stomatitis—Fluorouracil—head and neck cancer	0.00102	0.00592	CcSEcCtD
Captopril—Thrombocytopenia—Vinblastine—head and neck cancer	0.000993	0.00578	CcSEcCtD
Captopril—Hyponatraemia—Docetaxel—head and neck cancer	0.000982	0.00571	CcSEcCtD
Captopril—Agranulocytosis—Fluorouracil—head and neck cancer	0.000974	0.00567	CcSEcCtD
Captopril—Anorexia—Vinblastine—head and neck cancer	0.000967	0.00562	CcSEcCtD
Captopril—Discomfort—Hydroxyurea—head and neck cancer	0.000953	0.00555	CcSEcCtD
Captopril—Rhinitis—Fluorouracil—head and neck cancer	0.000939	0.00547	CcSEcCtD
Captopril—ACE—thyroid gland—head and neck cancer	0.000933	0.00347	CbGeAlD
Captopril—Pharyngitis—Fluorouracil—head and neck cancer	0.00093	0.00541	CcSEcCtD
Captopril—Ataxia—Docetaxel—head and neck cancer	0.000919	0.00535	CcSEcCtD
Captopril—Paraesthesia—Vinblastine—head and neck cancer	0.000911	0.0053	CcSEcCtD
Captopril—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000906	0.00527	CcSEcCtD
Captopril—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000893	0.0052	CcSEcCtD
Captopril—Anorexia—Hydroxyurea—head and neck cancer	0.000882	0.00513	CcSEcCtD
Captopril—Decreased appetite—Vinblastine—head and neck cancer	0.000882	0.00513	CcSEcCtD
Captopril—Constipation—Vinblastine—head and neck cancer	0.000867	0.00505	CcSEcCtD
Captopril—Feeling abnormal—Vinblastine—head and neck cancer	0.000836	0.00486	CcSEcCtD
Captopril—Bronchospasm—Docetaxel—head and neck cancer	0.000831	0.00484	CcSEcCtD
Captopril—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000829	0.00483	CcSEcCtD
Captopril—Alopecia—Fluorouracil—head and neck cancer	0.000828	0.00482	CcSEcCtD
Captopril—ACE—head—head and neck cancer	0.000828	0.00308	CbGeAlD
Captopril—Dyspnoea—Hydroxyurea—head and neck cancer	0.000825	0.0048	CcSEcCtD
Captopril—Angina pectoris—Docetaxel—head and neck cancer	0.000823	0.00479	CcSEcCtD
Captopril—Somnolence—Hydroxyurea—head and neck cancer	0.000822	0.00478	CcSEcCtD
Captopril—Dyspepsia—Hydroxyurea—head and neck cancer	0.000814	0.00474	CcSEcCtD
Captopril—Decreased appetite—Hydroxyurea—head and neck cancer	0.000804	0.00468	CcSEcCtD
Captopril—Pancytopenia—Docetaxel—head and neck cancer	0.000802	0.00467	CcSEcCtD
Captopril—Abdominal pain—Vinblastine—head and neck cancer	0.000802	0.00466	CcSEcCtD
Captopril—Fatigue—Hydroxyurea—head and neck cancer	0.000797	0.00464	CcSEcCtD
Captopril—Constipation—Hydroxyurea—head and neck cancer	0.000791	0.0046	CcSEcCtD
Captopril—Neutropenia—Docetaxel—head and neck cancer	0.00079	0.0046	CcSEcCtD
Captopril—Vision blurred—Fluorouracil—head and neck cancer	0.000769	0.00447	CcSEcCtD
Captopril—Weight decreased—Docetaxel—head and neck cancer	0.000764	0.00445	CcSEcCtD
Captopril—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000762	0.00443	CcSEcCtD
Captopril—Anaemia—Fluorouracil—head and neck cancer	0.000754	0.00439	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000747	0.00435	CcSEcCtD
Captopril—Renal failure—Docetaxel—head and neck cancer	0.000741	0.00431	CcSEcCtD
Captopril—Stomatitis—Docetaxel—head and neck cancer	0.000734	0.00427	CcSEcCtD
Captopril—Jaundice—Docetaxel—head and neck cancer	0.000734	0.00427	CcSEcCtD
Captopril—Body temperature increased—Hydroxyurea—head and neck cancer	0.000731	0.00425	CcSEcCtD
Captopril—Asthenia—Vinblastine—head and neck cancer	0.000728	0.00423	CcSEcCtD
Captopril—Agranulocytosis—Docetaxel—head and neck cancer	0.000703	0.00409	CcSEcCtD
Captopril—Chest pain—Fluorouracil—head and neck cancer	0.000694	0.00404	CcSEcCtD
Captopril—Myalgia—Fluorouracil—head and neck cancer	0.000694	0.00404	CcSEcCtD
Captopril—Diarrhoea—Vinblastine—head and neck cancer	0.000694	0.00404	CcSEcCtD
Captopril—Discomfort—Fluorouracil—head and neck cancer	0.000686	0.00399	CcSEcCtD
Captopril—Rhinitis—Docetaxel—head and neck cancer	0.000678	0.00394	CcSEcCtD
Captopril—Hepatitis—Docetaxel—head and neck cancer	0.000676	0.00393	CcSEcCtD
Captopril—Confusional state—Fluorouracil—head and neck cancer	0.000671	0.00391	CcSEcCtD
Captopril—Pharyngitis—Docetaxel—head and neck cancer	0.000671	0.00391	CcSEcCtD
Captopril—Dizziness—Vinblastine—head and neck cancer	0.000671	0.0039	CcSEcCtD
Captopril—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000666	0.00387	CcSEcCtD
Captopril—Asthenia—Hydroxyurea—head and neck cancer	0.000664	0.00386	CcSEcCtD
Captopril—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000652	0.00379	CcSEcCtD
Captopril—Tachycardia—Fluorouracil—head and neck cancer	0.00065	0.00378	CcSEcCtD
Captopril—Vomiting—Vinblastine—head and neck cancer	0.000645	0.00375	CcSEcCtD
Captopril—Erythema multiforme—Docetaxel—head and neck cancer	0.000639	0.00372	CcSEcCtD
Captopril—Headache—Vinblastine—head and neck cancer	0.000635	0.0037	CcSEcCtD
Captopril—Anorexia—Fluorouracil—head and neck cancer	0.000635	0.00369	CcSEcCtD
Captopril—Diarrhoea—Hydroxyurea—head and neck cancer	0.000633	0.00368	CcSEcCtD
Captopril—Flushing—Docetaxel—head and neck cancer	0.000628	0.00365	CcSEcCtD
Captopril—Hypotension—Fluorouracil—head and neck cancer	0.000622	0.00362	CcSEcCtD
Captopril—Dizziness—Hydroxyurea—head and neck cancer	0.000612	0.00356	CcSEcCtD
Captopril—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000607	0.00353	CcSEcCtD
Captopril—ALB—lymph node—head and neck cancer	0.000606	0.00225	CbGeAlD
Captopril—Nausea—Vinblastine—head and neck cancer	0.000602	0.0035	CcSEcCtD
Captopril—Insomnia—Fluorouracil—head and neck cancer	0.000602	0.0035	CcSEcCtD
Captopril—Paraesthesia—Fluorouracil—head and neck cancer	0.000598	0.00348	CcSEcCtD
Captopril—Alopecia—Docetaxel—head and neck cancer	0.000598	0.00348	CcSEcCtD
Captopril—Dyspnoea—Fluorouracil—head and neck cancer	0.000594	0.00345	CcSEcCtD
Captopril—Somnolence—Fluorouracil—head and neck cancer	0.000592	0.00344	CcSEcCtD
Captopril—Vomiting—Hydroxyurea—head and neck cancer	0.000588	0.00342	CcSEcCtD
Captopril—Dyspepsia—Fluorouracil—head and neck cancer	0.000586	0.00341	CcSEcCtD
Captopril—Rash—Hydroxyurea—head and neck cancer	0.000583	0.00339	CcSEcCtD
Captopril—Dermatitis—Hydroxyurea—head and neck cancer	0.000583	0.00339	CcSEcCtD
Captopril—ACE—lymph node—head and neck cancer	0.00058	0.00216	CbGeAlD
Captopril—Headache—Hydroxyurea—head and neck cancer	0.000579	0.00337	CcSEcCtD
Captopril—Decreased appetite—Fluorouracil—head and neck cancer	0.000579	0.00337	CcSEcCtD
Captopril—Dysgeusia—Docetaxel—head and neck cancer	0.000577	0.00335	CcSEcCtD
Captopril—Nausea—Hydroxyurea—head and neck cancer	0.000549	0.0032	CcSEcCtD
Captopril—Feeling abnormal—Fluorouracil—head and neck cancer	0.000549	0.00319	CcSEcCtD
Captopril—Anaemia—Docetaxel—head and neck cancer	0.000544	0.00317	CcSEcCtD
Captopril—Syncope—Docetaxel—head and neck cancer	0.000528	0.00307	CcSEcCtD
Captopril—Body temperature increased—Fluorouracil—head and neck cancer	0.000526	0.00306	CcSEcCtD
Captopril—Palpitations—Docetaxel—head and neck cancer	0.00052	0.00303	CcSEcCtD
Captopril—Loss of consciousness—Docetaxel—head and neck cancer	0.000517	0.00301	CcSEcCtD
Captopril—Cough—Docetaxel—head and neck cancer	0.000514	0.00299	CcSEcCtD
Captopril—Arthralgia—Docetaxel—head and neck cancer	0.000501	0.00292	CcSEcCtD
Captopril—Chest pain—Docetaxel—head and neck cancer	0.000501	0.00292	CcSEcCtD
Captopril—Myalgia—Docetaxel—head and neck cancer	0.000501	0.00292	CcSEcCtD
Captopril—Dry mouth—Docetaxel—head and neck cancer	0.00049	0.00285	CcSEcCtD
Captopril—Confusional state—Docetaxel—head and neck cancer	0.000484	0.00282	CcSEcCtD
Captopril—Anaphylactic shock—Docetaxel—head and neck cancer	0.00048	0.0028	CcSEcCtD
Captopril—Shock—Docetaxel—head and neck cancer	0.000473	0.00275	CcSEcCtD
Captopril—Pruritus—Fluorouracil—head and neck cancer	0.000471	0.00274	CcSEcCtD
Captopril—Thrombocytopenia—Docetaxel—head and neck cancer	0.00047	0.00274	CcSEcCtD
Captopril—ABCB1—epithelium—head and neck cancer	0.00047	0.00175	CbGeAlD
Captopril—Tachycardia—Docetaxel—head and neck cancer	0.000469	0.00273	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000462	0.00205	CbGpPWpGaD
Captopril—Anorexia—Docetaxel—head and neck cancer	0.000458	0.00266	CcSEcCtD
Captopril—MMP2—EPH-Ephrin signaling—HRAS—head and neck cancer	0.000457	0.00203	CbGpPWpGaD
Captopril—Diarrhoea—Fluorouracil—head and neck cancer	0.000455	0.00265	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—STAT3—head and neck cancer	0.00045	0.002	CbGpPWpGaD
Captopril—Hypotension—Docetaxel—head and neck cancer	0.000449	0.00261	CcSEcCtD
Captopril—Dizziness—Fluorouracil—head and neck cancer	0.00044	0.00256	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—PTGS2—head and neck cancer	0.000439	0.00195	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000438	0.00255	CcSEcCtD
Captopril—Insomnia—Docetaxel—head and neck cancer	0.000435	0.00253	CcSEcCtD
Captopril—Paraesthesia—Docetaxel—head and neck cancer	0.000431	0.00251	CcSEcCtD
Captopril—F2—Platelet Aggregation (Plug Formation)—AKT1—head and neck cancer	0.000431	0.00192	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000429	0.00191	CbGpPWpGaD
Captopril—Dyspnoea—Docetaxel—head and neck cancer	0.000428	0.00249	CcSEcCtD
Captopril—SLC15A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000428	0.0019	CbGpPWpGaD
Captopril—Somnolence—Docetaxel—head and neck cancer	0.000427	0.00249	CcSEcCtD
Captopril—MMP2—Extracellular matrix organization—CDH1—head and neck cancer	0.000426	0.00189	CbGpPWpGaD
Captopril—Vomiting—Fluorouracil—head and neck cancer	0.000423	0.00246	CcSEcCtD
Captopril—Dyspepsia—Docetaxel—head and neck cancer	0.000423	0.00246	CcSEcCtD
Captopril—Rash—Fluorouracil—head and neck cancer	0.00042	0.00244	CcSEcCtD
Captopril—Dermatitis—Fluorouracil—head and neck cancer	0.000419	0.00244	CcSEcCtD
Captopril—Decreased appetite—Docetaxel—head and neck cancer	0.000418	0.00243	CcSEcCtD
Captopril—Headache—Fluorouracil—head and neck cancer	0.000417	0.00243	CcSEcCtD
Captopril—ABCB1—trachea—head and neck cancer	0.000415	0.00155	CbGeAlD
Captopril—MMP9—EPH-Ephrin signaling—VEGFA—head and neck cancer	0.000415	0.00184	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.000415	0.00184	CbGpPWpGaD
Captopril—Fatigue—Docetaxel—head and neck cancer	0.000414	0.00241	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—EGFR—head and neck cancer	0.000414	0.00184	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—AKT1—head and neck cancer	0.000413	0.00183	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—GRP—head and neck cancer	0.000412	0.00183	CbGpPWpGaD
Captopril—Constipation—Docetaxel—head and neck cancer	0.000411	0.00239	CcSEcCtD
Captopril—MMP9—LPA receptor mediated events—HRAS—head and neck cancer	0.000408	0.00181	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL2—head and neck cancer	0.000407	0.00181	CbGpPWpGaD
Captopril—CYP2D6—head—head and neck cancer	0.000405	0.00151	CbGeAlD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000403	0.00179	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—head and neck cancer	0.000397	0.00176	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCND1—head and neck cancer	0.000397	0.00176	CbGpPWpGaD
Captopril—Feeling abnormal—Docetaxel—head and neck cancer	0.000396	0.0023	CcSEcCtD
Captopril—Nausea—Fluorouracil—head and neck cancer	0.000395	0.0023	CcSEcCtD
Captopril—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000393	0.00229	CcSEcCtD
Captopril—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000381	0.0017	CbGpPWpGaD
Captopril—Abdominal pain—Docetaxel—head and neck cancer	0.00038	0.00221	CcSEcCtD
Captopril—Body temperature increased—Docetaxel—head and neck cancer	0.00038	0.00221	CcSEcCtD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000375	0.00167	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TYMS—head and neck cancer	0.000369	0.00164	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GSTM1—head and neck cancer	0.000365	0.00162	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000364	0.00162	CbGpPWpGaD
Captopril—ABCB1—lymphoid tissue—head and neck cancer	0.000362	0.00135	CbGeAlD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.00036	0.0016	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—AKT1—head and neck cancer	0.00036	0.0016	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—AKT1—head and neck cancer	0.00036	0.0016	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—PIK3CA—head and neck cancer	0.000355	0.00158	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—AKT1—head and neck cancer	0.000351	0.00156	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GPX1—head and neck cancer	0.00035	0.00155	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—head and neck cancer	0.000348	0.00155	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CYP1A1—head and neck cancer	0.000346	0.00154	CbGpPWpGaD
Captopril—Asthenia—Docetaxel—head and neck cancer	0.000345	0.00201	CcSEcCtD
Captopril—Pruritus—Docetaxel—head and neck cancer	0.00034	0.00198	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.000339	0.00151	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PTEN—head and neck cancer	0.000332	0.00148	CbGpPWpGaD
Captopril—Diarrhoea—Docetaxel—head and neck cancer	0.000329	0.00191	CcSEcCtD
Captopril—ABCB1—thyroid gland—head and neck cancer	0.000328	0.00122	CbGeAlD
Captopril—MMP9—Spinal Cord Injury—MAPK3—head and neck cancer	0.000327	0.00145	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—head and neck cancer	0.000321	0.00143	CbGpPWpGaD
Captopril—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000321	0.00143	CbGpPWpGaD
Captopril—Dizziness—Docetaxel—head and neck cancer	0.000318	0.00185	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000318	0.00141	CbGpPWpGaD
Captopril—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000317	0.00141	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—MAPK1—head and neck cancer	0.000311	0.00138	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—EGFR—head and neck cancer	0.000311	0.00138	CbGpPWpGaD
Captopril—Vomiting—Docetaxel—head and neck cancer	0.000306	0.00178	CcSEcCtD
Captopril—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000303	0.00135	CbGpPWpGaD
Captopril—Rash—Docetaxel—head and neck cancer	0.000303	0.00176	CcSEcCtD
Captopril—Dermatitis—Docetaxel—head and neck cancer	0.000303	0.00176	CcSEcCtD
Captopril—Headache—Docetaxel—head and neck cancer	0.000301	0.00175	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—HRAS—head and neck cancer	0.0003	0.00133	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—STAT3—head and neck cancer	0.000297	0.00132	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000295	0.00131	CbGpPWpGaD
Captopril—ABCB1—head—head and neck cancer	0.000291	0.00108	CbGeAlD
Captopril—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000291	0.00129	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—AKT1—head and neck cancer	0.00029	0.00129	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—GRP—head and neck cancer	0.00029	0.00129	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000289	0.00128	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NOTCH1—head and neck cancer	0.000287	0.00128	CbGpPWpGaD
Captopril—Nausea—Docetaxel—head and neck cancer	0.000285	0.00166	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000284	0.00126	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—MAPK3—head and neck cancer	0.000284	0.00126	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—KISS1—head and neck cancer	0.000282	0.00126	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CDH1—head and neck cancer	0.00028	0.00124	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—MAPK1—head and neck cancer	0.00027	0.0012	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—head and neck cancer	0.00027	0.0012	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000263	0.00117	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—head and neck cancer	0.000261	0.00116	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00026	0.00116	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KISS1—head and neck cancer	0.000257	0.00114	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—PIK3CA—head and neck cancer	0.00024	0.00107	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00024	0.00107	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VEGFA—head and neck cancer	0.000235	0.00105	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PIK3CA—head and neck cancer	0.000234	0.00104	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GRP—head and neck cancer	0.000233	0.00103	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MAPK3—head and neck cancer	0.000222	0.000989	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—head and neck cancer	0.000222	0.000987	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—head and neck cancer	0.000217	0.000964	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MAPK1—head and neck cancer	0.000212	0.000941	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—head and neck cancer	0.000212	0.00094	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GRP—head and neck cancer	0.000211	0.000939	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—MAPK3—head and neck cancer	0.00021	0.000932	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—head and neck cancer	0.000206	0.000915	CbGpPWpGaD
Captopril—ABCB1—lymph node—head and neck cancer	0.000204	0.00076	CbGeAlD
Captopril—F2—Regulation of Actin Cytoskeleton—MAPK1—head and neck cancer	0.0002	0.000887	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—head and neck cancer	0.000199	0.000887	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000199	0.000886	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—head and neck cancer	0.000199	0.000882	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KISS1—head and neck cancer	0.000196	0.000872	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—AKT1—head and neck cancer	0.000191	0.000851	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.00019	0.000846	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NOTCH1—head and neck cancer	0.000188	0.000836	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTEN—head and neck cancer	0.000179	0.000798	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—PIK3CA—head and neck cancer	0.000173	0.00077	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00017	0.000756	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—head and neck cancer	0.00017	0.000755	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—head and neck cancer	0.000168	0.000746	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—STAT3—head and neck cancer	0.000166	0.000738	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000165	0.000734	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000162	0.000719	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GRP—head and neck cancer	0.000162	0.000718	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MAPK3—head and neck cancer	0.000159	0.000705	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT6—head and neck cancer	0.000157	0.000697	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000156	0.000695	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—head and neck cancer	0.000154	0.000686	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000153	0.00068	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KISS1—head and neck cancer	0.000152	0.000674	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MAPK1—head and neck cancer	0.000151	0.000671	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—head and neck cancer	0.000151	0.000671	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000151	0.00067	CbGpPWpGaD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000149	0.000662	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000149	0.000661	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000149	0.000661	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000148	0.000657	CbGpPWpGaD
Captopril—ALB—Metabolism—UROD—head and neck cancer	0.000147	0.000654	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MAPK3—head and neck cancer	0.000146	0.000648	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000146	0.000648	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000146	0.000647	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000145	0.000643	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000145	0.000643	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000144	0.000642	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000144	0.00064	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000144	0.000639	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—YAP1—head and neck cancer	0.000139	0.000617	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MAPK1—head and neck cancer	0.000139	0.000617	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—head and neck cancer	0.000139	0.000617	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000138	0.000614	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000138	0.000613	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000136	0.000606	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000129	0.000574	CbGpPWpGaD
Captopril—ABCB1—Metabolism—UROD—head and neck cancer	0.000129	0.000573	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000128	0.000569	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—head and neck cancer	0.000127	0.000567	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CA—head and neck cancer	0.000127	0.000563	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000126	0.000561	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GRP—head and neck cancer	0.000125	0.000555	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—UROD—head and neck cancer	0.000122	0.00054	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—head and neck cancer	0.000121	0.000539	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT6—head and neck cancer	0.000121	0.000538	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000119	0.000531	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000114	0.000508	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—head and neck cancer	0.000111	0.000495	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—head and neck cancer	0.00011	0.000489	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—head and neck cancer	0.000109	0.000484	CbGpPWpGaD
Captopril—F2—Signaling Pathways—YAP1—head and neck cancer	0.000107	0.000477	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—head and neck cancer	0.000107	0.000476	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK3—head and neck cancer	0.000104	0.000463	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—head and neck cancer	0.000103	0.00046	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000103	0.000459	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK1—head and neck cancer	9.91e-05	0.00044	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—head and neck cancer	9.9e-05	0.00044	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.84e-05	0.000437	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—head and neck cancer	9.81e-05	0.000436	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	9.43e-05	0.000419	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	8.44e-05	0.000375	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—head and neck cancer	8.34e-05	0.000371	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.02e-05	0.000357	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—head and neck cancer	7.95e-05	0.000353	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK3—head and neck cancer	7.89e-05	0.000351	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	7.55e-05	0.000336	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK1—head and neck cancer	7.5e-05	0.000334	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.25e-05	0.000322	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—head and neck cancer	7.02e-05	0.000312	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7e-05	0.000311	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—head and neck cancer	6.51e-05	0.000289	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.49e-05	0.000289	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.43e-05	0.000286	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	6.42e-05	0.000285	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.32e-05	0.000281	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—head and neck cancer	6.3e-05	0.00028	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—head and neck cancer	6.26e-05	0.000278	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—head and neck cancer	6.2e-05	0.000276	CbGpPWpGaD
Captopril—ALB—Metabolism—NAT2—head and neck cancer	6.11e-05	0.000272	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	6.07e-05	0.00027	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—head and neck cancer	6.02e-05	0.000268	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.98e-05	0.000266	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	5.78e-05	0.000257	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.69e-05	0.000253	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.69e-05	0.000253	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—head and neck cancer	5.63e-05	0.00025	CbGpPWpGaD
Captopril—ALB—Metabolism—DPYD—head and neck cancer	5.36e-05	0.000238	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NAT2—head and neck cancer	5.36e-05	0.000238	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—head and neck cancer	5.32e-05	0.000236	CbGpPWpGaD
Captopril—ALB—Metabolism—YAP1—head and neck cancer	5.09e-05	0.000226	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NAT2—head and neck cancer	5.05e-05	0.000224	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	5.01e-05	0.000223	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.93e-05	0.000219	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—head and neck cancer	4.83e-05	0.000215	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.77e-05	0.000212	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DPYD—head and neck cancer	4.7e-05	0.000209	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK3—head and neck cancer	4.53e-05	0.000201	CbGpPWpGaD
Captopril—ABCB1—Metabolism—YAP1—head and neck cancer	4.46e-05	0.000198	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DPYD—head and neck cancer	4.43e-05	0.000197	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—head and neck cancer	4.31e-05	0.000191	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK1—head and neck cancer	4.31e-05	0.000191	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—head and neck cancer	4.31e-05	0.000191	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—YAP1—head and neck cancer	4.2e-05	0.000187	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—head and neck cancer	4.2e-05	0.000187	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—head and neck cancer	4.11e-05	0.000183	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	4.09e-05	0.000182	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—head and neck cancer	4.05e-05	0.00018	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.03e-05	0.000179	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—head and neck cancer	3.89e-05	0.000173	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.82e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—head and neck cancer	3.74e-05	0.000166	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—head and neck cancer	3.66e-05	0.000163	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—head and neck cancer	3.62e-05	0.000161	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK3—head and neck cancer	3.46e-05	0.000154	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—head and neck cancer	3.46e-05	0.000154	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—head and neck cancer	3.36e-05	0.000149	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.33e-05	0.000148	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—head and neck cancer	3.33e-05	0.000148	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—head and neck cancer	3.31e-05	0.000147	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK1—head and neck cancer	3.29e-05	0.000146	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—head and neck cancer	3.29e-05	0.000146	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—head and neck cancer	3.24e-05	0.000144	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK3—head and neck cancer	3.13e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—head and neck cancer	3.13e-05	0.000139	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMS—head and neck cancer	3.06e-05	0.000136	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—head and neck cancer	3.05e-05	0.000136	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—head and neck cancer	3.02e-05	0.000134	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK1—head and neck cancer	2.98e-05	0.000132	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—head and neck cancer	2.89e-05	0.000129	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1A1—head and neck cancer	2.86e-05	0.000127	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—head and neck cancer	2.86e-05	0.000127	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—head and neck cancer	2.83e-05	0.000126	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—head and neck cancer	2.8e-05	0.000124	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—head and neck cancer	2.77e-05	0.000123	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMS—head and neck cancer	2.68e-05	0.000119	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK3—head and neck cancer	2.67e-05	0.000119	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—head and neck cancer	2.65e-05	0.000118	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—head and neck cancer	2.64e-05	0.000118	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—head and neck cancer	2.58e-05	0.000115	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK1—head and neck cancer	2.54e-05	0.000113	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—head and neck cancer	2.54e-05	0.000113	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—head and neck cancer	2.53e-05	0.000113	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMS—head and neck cancer	2.52e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.51e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—head and neck cancer	2.5e-05	0.000111	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.49e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—head and neck cancer	2.39e-05	0.000106	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—head and neck cancer	2.39e-05	0.000106	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.36e-05	0.000105	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.35e-05	0.000105	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—head and neck cancer	2.34e-05	0.000104	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—head and neck cancer	2.21e-05	9.81e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—head and neck cancer	2.14e-05	9.49e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—head and neck cancer	2.11e-05	9.38e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—head and neck cancer	2.04e-05	9.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—head and neck cancer	1.8e-05	8.01e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—head and neck cancer	1.7e-05	7.57e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—head and neck cancer	1.49e-05	6.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—head and neck cancer	1.48e-05	6.6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.41e-05	6.25e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—head and neck cancer	1.3e-05	5.78e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—head and neck cancer	1.23e-05	5.45e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—head and neck cancer	1.05e-05	4.66e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—head and neck cancer	9.18e-06	4.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—head and neck cancer	8.65e-06	3.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—head and neck cancer	8.56e-06	3.8e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—head and neck cancer	7.5e-06	3.33e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—head and neck cancer	7.06e-06	3.14e-05	CbGpPWpGaD
